Key result
Moderately abnormal LVEF showed no difference compared to normal LVEF in acute complications or target vessel failure following percutaneous coronary intervention.
Why the study?
Left ventricular systolic dysfunction has traditionally favored coronary artery bypass surgery over PCI, but recent data have challenged this concept.
Does ejection fraction matter in choosing between percutaneous coronary intervention and coronary artery bypass surgery?
Does ejection fraction matter in choosing between percutaneous coronary intervention and coronary artery bypass surgery?
Answers are grounded in this paper and cite their sources.
Moderately abnormal LVEF (30%-50%) may no longer be a relative contraindication to PCI, as outcomes like target vessel failure do not differ significantly from those with normal LVEF.
Key points Left ventricular systolic dysfunction has traditionally been used as a risk factor favoring coronary artery bypass surgery over percutaneous coronary intervention (PCI), but recent data have challenged this. Retrospective data from the BIOFLOW trials show no difference between normal and moderately abnormal LVEF (30%–50%) in acute complications or target vessel failure. Abnormal LVEF may be a marker for comorbidities but no longer a relative contraindication to PCI.
No takes yet. Share an insight, caveat, or question.
Seto et al. (2024) conducted a review in Left ventricular systolic dysfunction. Moderately abnormal LVEF (30%-50%) vs. Normal LVEF was evaluated on Acute complications or target vessel failure. Moderately abnormal LVEF showed no difference compared to normal LVEF in acute complications or target vessel failure following percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: